1Waiters M R.Newly identified actions of the vitamin D endocrine system [J]. Endocrine Reviews.1992,13(4):719.
2Woiff J A, Malone R W, et al.Direct gene transfer into mouse muscle in vivo[J]. Science.1990,247:1465.
3Ledley F D, Nonviral gene therapy: The promise of genes as pharmaceutical produets[M].Hum Gen Ther,1995,6:1129.
4homas J G, David R A, et al. Exprission of Human Parathyroid Hormone (1-84) in Escheri- -chia coli as a Factor X- cleavable Fusion Protein [J].The Journal of Biological chenustry, 1990,265 (26):15854-15859.
9萨姆布鲁克 J 拉塞尔D W 黄培堂译.分子克隆实验指南 第3版[M].北京:科学出版社,2002.518-522.
10Tanaka F, Hashimoto W, Bobbins PD, et al. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL18. Gene Ther,2002,9 : 1480-1486.
4Morinaga T, Nakagawa N, Y asnda I-I, et al. Cloning and characterization of the gene encoding human osteoprotegerin/ osteoclasto-genesis inhibitory factor[ J]. Eur J Biochem, 1998, 254 : 685.
5Yun TJ, Chaudhary PM, Shu GL, et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up- regulated by ligating CD40 [ J ]. J Immunol, 1998, 161 ( 11 ) : 6113 -6121.
6Simonet WS, Lacey D, Dunstan C, et al. Osteoprogerin: a novel secreted protein involved in the regulation of bone density [ J]. Cell, 1997, 89:309-319.
7Yamaguchi K, Kinosaki M, Goto M, et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor[J]. JBiochem, 1998, 273(9): 5117 -5123.
9Galibert L, Tometsko ME, Anderson DM, et aL The involvement of multiple tumor necrosis factor receptor (TNFR)- associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily[ J]. J Biol Chem. 1998, 273(51): 34120 -34127.
10Ye H, Arron JR, Lamothe B, Cirilli M, et al. Dis-tinct molecular mechanism for initiating TRAF6 signalling [ J ]. Nature, 2002, 418 ( 6896 ) :443 - 447.
